CAS 2130836-27-8 Imsamotide

Send Inquiry
CAS 2130836-27-8 Imsamotide
Details
CAS: 2130836-27-8
Core structure: Synthetic immunostimulatory CpG derivative, phosphorothioate backbone modification for enhanced nuclease resistance
We also provide specifications from crude to 99% purity, please contact us for details!

Related documents
COA/MS/HPLC Report
Peptide Dissolution and Storage Guide
Category
Immunomodulatory Derivative / TLR9 Agonist Immune Adjuvant
Category
Pharmaceutical Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cas 2130836-27-8 imsamotide in China, also supports custom service. Welcome to wholesale bulk high quality cas 2130836-27-8 imsamotide from our factory. Contact us for more details.

 

Product name CAS:2130836‑27‑8 Imsamotide
Description Imsamotide is a new‑generation synthetic immunostimulant. It specifically activates TLR9 receptors, induces innate immune responses, promotes dendritic cell maturation and proinflammatory cytokine release, and enhances antigen‑specific immune responses. Used as a vaccine adjuvant in tumor immunotherapy, infectious disease vaccines and immune mechanism research.
Purity (HPLC, %) 90%/95%/98%
Theoretical molecular weight ~6.8 kDa
Modification type Phosphorothioate backbone modification for enhanced stability

 

Products Description

 

Product Standard English Name Product Abbreviation / Alias Function Tags (comma-separated) Core Structure Molecular Formula Exact Mass (Da) Average MW (Da) Modification Type Structure Length
Imsamotide Imsamotide; Immunostimulatory CpG derivative; TLR9 agonist; CAS 2130836-27-8 TLR9 receptor agonism,Immune adjuvant,Innate immune activation,Tumor immunotherapy,Vaccine enhancer,Dendritic cell activation Immunostimulatory backbone with CpG motifs, phosphorothioate modification for nuclease resistance Large macromolecular derivative, no precise small-molecule formula; subject to actual batch MS - ~6800 (theoretical) Phosphorothioate backbone modification Multiple immunostimulatory motifs

 

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Conditions Short-term Storage Conditions Liquid Stability Solid Powder Stability
PEP-IMS001 white powder Store at -20℃, strictly protected from light, sealed and aliquoted; avoid repeated freeze-thaw and nuclease contamination Solid powder stable for 1 year at 2-8℃ sealed and dry; prepare solutions with nuclease-free water Stable for 1 month at 4℃ under sterile & nuclease-free conditions; stable for 6 months at -20℃ in aliquots. **Excellent water solubility, freely soluble in nuclease-free water and physiological buffer**. Easily degraded by nucleases; use nuclease-free consumables and buffers. Sensitive to UV light and prone to degradation Stable for over 2 years at -20℃ under dry & dark conditions

 

Functional Description

 

Product Code Frontend Short Summary (for search list display) Detailed Biological Function Description Applicable Research Areas (comma-separated) Targets / Pathways
PEP-IMS001 Selective TLR9 agonist that potently activates innate immunity and enhances specific immune responses as a vaccine adjuvant Imsamotide is a structurally optimized synthetic immunostimulant. After endocytosis by immune cells, it specifically binds to TLR9 receptors on endosomal membranes, triggers downstream NF-κB, MAPK and other signaling pathways, induces activation and maturation of dendritic cells and macrophages, promotes release of proinflammatory cytokines such as IL-6, TNF-α, IFN-α and type I interferons, and comprehensively activates innate immune responses. It also significantly enhances the immunogenicity of co-delivered antigens, elevates antigen-specific antibody and T cell response levels. As a high-efficiency immune adjuvant, it is applied in research fields such as tumor therapeutic vaccines, infectious disease vaccines and allergic immunotherapy, and serves as a core tool molecule for innate immune activation mechanism and TLR signaling pathway research. Tumor immunity research,Vaccine adjuvant development,Innate immunity mechanism study,TLR pathway study,Infection immunity research,Dendritic cell research Toll-Like Receptor 9 (TLR9); NF-κB and MAPK signaling pathways; Innate immune activation and adjuvant effect pathway

Hot Tags: cas 2130836-27-8 imsamotide, China cas 2130836-27-8 imsamotide manufacturers, suppliers, factory, 129954-34-3, 1415456-99-3, 1566590-77-9, CAS 1566590 77 9, CAS 910463 68 2, Melanotan II

Send Inquiry